Beat the S&P 500 With This Cash-Gushing Dividend Stock
The business may be somewhat boring, but it consistently delivers year after year, resulting in tremendous long-term returns.
You don't need to uncover the next big artificial intelligence stock to outperform the broader stock market. Sometimes, consistent and profitable growth is all you need to achieve outsize investment returns.
Zoetis (NYSE: ZTS) is an animal healthcare company that split off from Pfizer in 2013. The stock has beaten the S&P 500 ever since, and now may be as good an opportunity as any to buy the stock.
Here is why Zoetis is a compelling buy today, and why investors can continue to expect outstanding investment returns over the coming years.
